Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
Eltroxin 25mcg tablets.
Levothyroxine 25mcg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Each tablet is engraved on one face with “LT” and 25 on the other. |
Each tablet contains 25 micrograms Levothyroxine sodium anhydrous.
Excipients with known effect: Lactose 30.49mg per tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levothyroxine |
Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism. |
| List of Excipients |
|---|
|
Sodium citrate |
Polypropylene container with tamper-evident low density polyethylene lid, containing 28, 56, 100, 112, 500 or 1000 tablets.
Aluminium foil with PVC/PVdC film blisters containing 28, 56 or 112 tablets.
Not all pack sizes may be marketed.
Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0016
17/11/1999
| Drug | Countries | |
|---|---|---|
| ELTROXIN | Canada, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
